Incidence, characteristics, and prognostic significance of early recurrences after different ablation approaches for persistent atrial fibrillation.

IF 5.6 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Heart rhythm Pub Date : 2024-12-30 DOI:10.1016/j.hrthm.2024.12.031

Sohaib A Virk, David Chieng, Louise Segan, Joseph B Morton, Geoffrey Lee, Paul Sparks, Alex J McLellan, Hariharan Sugumar, Sandeep Prabhu, Liang-Han Ling, Aleksandr Voskoboinik, Rajeev K Pathak, Laurence D Sterns, Matthew Ginks, Prashanthan Sanders, Peter Kistler, Jonathan Kalman

{"title":"Incidence, characteristics, and prognostic significance of early recurrences after different ablation approaches for persistent atrial fibrillation.","authors":"Sohaib A Virk, David Chieng, Louise Segan, Joseph B Morton, Geoffrey Lee, Paul Sparks, Alex J McLellan, Hariharan Sugumar, Sandeep Prabhu, Liang-Han Ling, Aleksandr Voskoboinik, Rajeev K Pathak, Laurence D Sterns, Matthew Ginks, Prashanthan Sanders, Peter Kistler, Jonathan Kalman","doi":"10.1016/j.hrthm.2024.12.031","DOIUrl":null,"url":null,"abstract":"Background: Early recurrence of atrial tachyarrhythmia (ERAT) is common after catheter ablation of atrial fibrillation (AF). The specific clinical and arrhythmia characteristics of ERAT influencing late recurrence risk in persistent AF are unclear. In addition, the impact of different ablation strategies on the incidence and prognostic significance of ERAT remains unknown.Objective: This study aimed to assess the incidence, characteristics, and prognostic impact of ERAT in patients with persistent AF undergoing pulmonary vein isolation alone or pulmonary vein isolation with posterior wall isolation.Methods: Trial participants monitored by implantable cardiac devices or twice-daily electrocardiogram transmissions were included. Atrial arrhythmia recurrences lasting ≥30 seconds were classified as ERAT (within 3 months after ablation) or late recurrence (between 3 and 12 months).Results: Of the 282 included patients, ERAT occurred in 124 (44.0%). ERAT portended an increased incidence of late recurrence (68.5% vs 32.9%; hazard ratio, 3.36; 95% confidence interval, 2.35-4.79) and significantly higher post-blanking period AF burden (median, 0.66% [interquartile range, 0-8.35%] vs 0% [0-0.55%]). The hazard ratio for late recurrence was 2.34 (1.48-3.71), 2.89 (1.63-5.12), and 6.00 (3.86-9.32) when the latest ERAT occurred in the first, second, and third month, respectively. Late recurrence risk was particularly elevated in patients with high-burden, frequent, or symptomatic ERAT. Ablation strategy did not affect the incidence, burden, arrhythmia characteristics, or prognostic significance of ERAT.Conclusion: ERAT after radiofrequency ablation of persistent AF is an independent predictor of late recurrence and increased post-blanking period AF burden. An individualized assessment of early recurrences is warranted to critically evaluate their clinical significance.","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2024-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.hrthm.2024.12.031","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Early recurrence of atrial tachyarrhythmia (ERAT) is common after catheter ablation of atrial fibrillation (AF). The specific clinical and arrhythmia characteristics of ERAT influencing late recurrence risk in persistent AF are unclear. In addition, the impact of different ablation strategies on the incidence and prognostic significance of ERAT remains unknown.

Objective: This study aimed to assess the incidence, characteristics, and prognostic impact of ERAT in patients with persistent AF undergoing pulmonary vein isolation alone or pulmonary vein isolation with posterior wall isolation.

Methods: Trial participants monitored by implantable cardiac devices or twice-daily electrocardiogram transmissions were included. Atrial arrhythmia recurrences lasting ≥30 seconds were classified as ERAT (within 3 months after ablation) or late recurrence (between 3 and 12 months).

Results: Of the 282 included patients, ERAT occurred in 124 (44.0%). ERAT portended an increased incidence of late recurrence (68.5% vs 32.9%; hazard ratio, 3.36; 95% confidence interval, 2.35-4.79) and significantly higher post-blanking period AF burden (median, 0.66% [interquartile range, 0-8.35%] vs 0% [0-0.55%]). The hazard ratio for late recurrence was 2.34 (1.48-3.71), 2.89 (1.63-5.12), and 6.00 (3.86-9.32) when the latest ERAT occurred in the first, second, and third month, respectively. Late recurrence risk was particularly elevated in patients with high-burden, frequent, or symptomatic ERAT. Ablation strategy did not affect the incidence, burden, arrhythmia characteristics, or prognostic significance of ERAT.

Conclusion: ERAT after radiofrequency ablation of persistent AF is an independent predictor of late recurrence and increased post-blanking period AF burden. An individualized assessment of early recurrences is warranted to critically evaluate their clinical significance.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Heart rhythm 医学-心血管系统

CiteScore

10.50

自引率

5.50%

发文量

1465

审稿时长

24 days

期刊介绍： HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.